Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
Status: | Unknown status |
---|---|
Conditions: | Lung Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 19 - Any |
Updated: | 12/14/2017 |
Start Date: | December 2013 |
End Date: | June 2016 |
Contact: | KM Munirul Islam, MD, PhD |
Email: | kmislam@unmc.edu |
Phone: | 402-559-8283 |
Our long-term goal is to integrate non-small cell lung cancer patient treatment preferences
into clinical treatment planning.
into clinical treatment planning.
The following specific aims are proposed:
Aim 1: Determine whether individual patients' preferences, characteristics, and treatment
experiences affect the definition of treatment success.
Aim 2: Determine how to best predict real-life patients' treatment choices based on patients'
preferences of adverse events.
Aim 3: Determine whether physicians are likely to change their oncologic clinical practice
after receiving a detailed communication of their patients' preferences of adverse events.
Aim 1: Determine whether individual patients' preferences, characteristics, and treatment
experiences affect the definition of treatment success.
Aim 2: Determine how to best predict real-life patients' treatment choices based on patients'
preferences of adverse events.
Aim 3: Determine whether physicians are likely to change their oncologic clinical practice
after receiving a detailed communication of their patients' preferences of adverse events.
Inclusion Criteria:
- Willing and able to provide consent
- Greater than or equal to 19 years of age
- Diagnosed with stage IV non-small cell lung cancer (NSCLC)
- Able to understand spoken English
- Eligible to undergo chemotherapy for stage IV NSCLC, to include, but not limited to,
those who:
1. have not yet started chemo
2. are currently undergoing chemo for stage IV NSCLC
3. have completed first line stage IV NSCLC chemo or progressed to maintenance for
stage IV NSCLC within the last 30 days
4. elect to have chemo elsewhere -- not at one of the study sites
5. decline chemo
Exclusion Criteria:
- Age <19 years
- Not willing and/or able to provide consent
- Not able to understand spoken English
- Not eligible to undergo chemotherapy for stage IV NSCLC
We found this trial at
8
sites
Avera Cancer Institute Avera, the health ministry of the Benedictine and Presentation Sisters, is a...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
North Platte, Nebraska 69103
Phone: 308-696-7864
Click here to add this to my saved trials
Click here to add this to my saved trials
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
Click here to add this to my saved trials
Click here to add this to my saved trials